Barclays’s Cano Health, Inc. CANO Stock Holding History

Barclays’s Portfolio CANO Stock Details CANO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-3,599	Closed	-$21.1K	–	5495
2023 Q4	$21.1K	Buy	3,599 +2,402	+201%	+$28.4K	﹤0.01%	4899
2023 Q3	$30.3K	Sell	1,197 -5,161	-81%	-$424K	﹤0.01%	4055
2023 Q2	$884K	Buy	6,358 +254	+4%	+$32.6K	﹤0.01%	2387
2023 Q1	$555K	Buy	6,104 +5,384	+748%	+$731K	﹤0.01%	3193
2022 Q4	$98.6K	Sell	720 -15,684	-96%	-$5.31M	﹤0.01%	4229
2022 Q3	$14.2M	Sell	16,404 -461	-3%	-$289K	0.02%	726
2022 Q2	$7.39M	Sell	16,865 -6,693	-28%	-$3.49M	﹤0.01%	1140
2022 Q1	$15M	Buy	+23,558	New	+$14.9M	0.01%	784

Other funds holding CANO

SOW

State of Wyoming Cheyenne, Wyoming $989M AUM 52.24% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

GFPC

Global Financial Private Client Sarasota, Florida $369M AUM 34.4% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Castleview Partners Dallas, Texas $228M AUM 19.85% 1-Year Est. Return

Barclays's CANO Position: Q1 2024 in Review

Barclays sold out of Cano Health, Inc. (CANO) in Q1 2024, closing a stake of 3,599 shares — an estimated $21.1K sold.

Barclays first reported a position in CANO in Q1 2022 and held it in 8 quarters. The position peaked at $15M in Q1 2022. 6 funds tracked by Wall St. Rank hold CANO as of Q1 2024.

Barclays reported no remaining Cano Health, Inc. position as of Q1 2024 after selling out during the quarter.
Barclays sold 3,599 Cano Health, Inc. shares in Q1 2024, an estimated $21.1K.
Barclays first reported a position in Cano Health, Inc. in Q1 2022 and held it in 8 quarters.
Barclays's Cano Health, Inc. position peaked at $15M in Q1 2022.
6 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q1 2024.

Based on Barclays's 13F filing for Q1 2024, filed 15 May 2024.